Clinical Trial Update: PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

View source ↗

Summary

The NYU Langone Health-sponsored clinical trial evaluating pericoronary inflammation in non-obstructive coronary atherosclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-obstructive Coronary Atherosclerosis

Snippet

Sponsor: NYU Langone Health | Conditions: Non-Obstructive Coronary Atherosclerosis | Status: TERMINATED